Back

Medication equity and sex differences in the CT-FFR guided management of patients with stable coronary artery disease: from the TARGET randomized trial

29 August 2025 (13:15 - 14:00)
Organised by: Logo
Congress Presentation Part of: Technical advances in cardiac-computed tomography Computed Tomography Derived Fractional Flow Reserve (FFR-CT) ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Junjie Yang

Chinese PLA General Hospital, Beijing (China)

6 More presentations in this session

Presentation thumbnail
Coronary artery calcium is associated with the onset and progression of calcific aortic valve disease
Doctor J. Seo (Pohang, KR)
Abstract Slides Video
Presentation thumbnail
Impact of an interactive CTCA/FFRCT interventional stent planning tool on patient management
Doctor D. Murphy (Bath, GB)
Abstract Slides Video
Presentation thumbnail
Optimizing stenosis quantification by a novel interpolation-based approach: diagnostic performance data from CREDENCE AND PACIFIC-1
Doctor S. Cramer (Amsterdam, NL)
Abstract Slides Video
Presentation thumbnail
Combination of pre-operative computed tomography-derived longitudinal strain and extracellular volume fraction is a useful prognostic marker after transcatheter aortic valve replacement
Ms M. Matsumoto (Chiba, JP)
Abstract Slides Video
Presentation thumbnail
Dynamic quantitative perfusion by computed tomography (CT) and cardiac magnetic resonance (CMR) in stented patients: a sub-analysis of ADVANTAGE II study
Doctor S. Mushtaq (Milan, IT)
Abstract Slides

Access the full session

Session thumbnail
Technical advances in cardiac-computed tomography

The Event

Event poster

ESC Congress 2025

29 August 2025 13:15 CET
You may be interested in
thumbnail
Congress Session
Advances in Science in cardiac computed tomography
thumbnail
Congress Presentation
Sex differences in long-term outcomes of coronary CT guided management for patients with stable chest pain: the SCOT-HEART trial
thumbnail
Congress Presentation
An exploration of sex differences in pharmacotherapy following invasive angiography for coronary artery disease

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources